A prenylation inhibitor prevents production of infectious hepatitis delta virus particles

Journal of Virology

Volumn 76, Issue 20, 2002, Pages 10465-10472

  Bordier, Bruno B ^a   Marion, Patricia L ^a   Ohashi, Kazuo ^a   Kay, Mark A ^a   Greenberg, Harry B ^a   Casey, John L ^a   Glenn, Jeffrey S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE METHYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPE; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFECTIOUS HEPATITIS; NORTHERN BLOTTING; PRENYLATION; PRIORITY JOURNAL; VIRION; VIRUS PARTICLE;

ALKYL AND ARYL TRANSFERASES; CELLS, CULTURED; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; HEPATITIS DELTA VIRUS; HEPATOCYTES; HUMANS; METHIONINE; PROTEIN ISOPRENYLATION; TUMOR CELLS, CULTURED; VIRION; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0036785539     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.20.10465-10472.2002     Document Type: Article

References (50)

1. Bonino, F., B. Hoyer, J. W. Shih, M. Rizzetto, R. H. Purcell, and J. L. Gerin. 1984. Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect. Immun. 43:1000-1005.
2. Casey, J. L. 1998. Hepatitis delta virus: molecular biology, pathogenesis and immunology. Antivir. Therapy 3:37-42.
3. Casey, J. L., T. L. Brown, E. J. Colan, F. S. Wignall, and J. L. Gerin. 1993. A genotype of hepatitis D virus that occurs in northern South America. Proc. Natl. Acad. Sci. USA 90:9016-9020.
4. Casey, J. L., and J. L. Gerin. 1998. Genotype-specific complementation of hepatitis delta virus RNA replication by hepatitis delta antigen. J. Virol. 72:2806-2814.
5. Casey, J. L., and J. L. Gerin. 1995. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Virol. 69:7593-7600.
6. Casey, J. L., G. A. Niro, R. E. Engle, A. Vega, H. Gomez, M. McCarthy, D. M. Watts, K. C. Hyams, and J. L. Gerin. 1996. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J. Infect. Dis. 174:920-926.
7. Casey, P. J., P. A. Solski, C. J. Der, and J. E. Buss. 1989. p21ras is modified by a farnesyl isoprenoid. Proc. Natl. Acad. Sci. USA 86:8323-8327.
8. Chang, F. L., P. J. Chen, S. J. Tu, C. J. Wang, and D. S. Chen. 1991. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus. Proc. Natl. Acad. Sci. USA. 88:8490-8494.
9. Chen, Y., and P. L. Marion. 1996. Amino acids essential for RNase H activity of hepadnaviruses are also required for efficient elongation of minus-strand viral DNA. J. Virol. 70:6151-6156.
10. Dalton, M. B., K. S. Fantle, H. A. Bechtold, L. DeMaio, R. M. Evans, A. Krystosek, and M. Sinensky. 1995. The farnesyl protein transferase inhibitor BZA-5B blocks farnesylation of nuclear lamins and p21ras but does not affect their function or localization. Cancer Res. 55:3295-3304.
11. Der, C. J., and A. D. Cox. 1991. Isoprenoid modification and plasma membrane association: critical factors for ras oncogenicity. Cancer Cells 3:331-340.
12. Galibert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
13. Ganem, D. 1991. Assembly of hepadnaviral virions and subviral particles. Curr. Top. Microbiol. Immunol. 168:61-83.
14. Gerin, J. L. 2001. Animal models of hepatitis delta virus infection and disease. Ilar J. 42:103-106.
15. Glenn, J. S. 1999. Shutting the door on hepatitis delta virus (HDV): Sensitivity to prenylation inhibition prompts new therapeutic strategy. Viral Hepatitis Rev. 5:13-26.
16. Glenn, J. S., J. C. Marsters, Jr., and H. B. Greenberg. 1998. Use of a prenylation inhibitor as a novel antiviral agent. J. Virol. 72:9303-9306.
17. Glenn, J. S., J. M. Taylor, and J. M. White. 1990. In vitro-synthesized hepatitis delta virus RNA initiates genome replication in cultured cells. J. Virol. 64:3104-3107.
18. Glenn, J. S., J. A. Watson, C. M. Havel, and J. M. White. 1992. Identification of a prenylation site in delta virus large antigen. Science 256:1331-1333.
19. Hancock, J. F., A. I. Magee, J. E. Childs, and C. J. Marshall. 1989. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57: 1167-1177.
20. Hoofnagle, J. H. 1989. Type D (delta) hepatitis. JAMA 261:1321-1325.
21. Hourioux, C., C. Sureau, F. Poisson, D. Brand, A. Goudeau, and P. Roingeard. 1998. Interaction between hepatitis delta virus-encoded proteins and hepatitis B virus envelope protein domains. J. Gen. Virol. 79:1115-1119.
22. James, G. L., M. S. Brown, M. H. Cobb, and J. L. Goldstein. 1994. Benzodiazepine peptidomimetic BZA-5B interrupts the MAP kinase activation pathway in H-Ras-transformed Rat-1 cells, but not in untransformed cells. J. Biol. Chem. 269:27705-27714.
23. Kuo, M. Y., M. Chao, and J. Taylor. 1989. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J. Virol. 63:1945-1950.
24. Lai, M. M. 1995. The molecular biology of hepatitis delta virus. Annu. Rev. Biochem. 64:259-286.
25. Lazinski, D. W., and J. M. Taylor. 1994. Recent developments in hepatitis delta virus research. Adv. Virus Res. 43:187-231.
26. Lee, C. Z., P. J. Chen, and D. S. Chen. 1995. Large hepatitis delta antigen in packaging and replication inhibition: role of the carboxyl-terminal 19 amino acids and amino-terminal sequences. J. Virol. 69:5332-5336.
27. Lee, C. Z., P. J. Chen, M. M. Lai, and D. S. Chen. 1994. Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly. Virology 199:169-175.
28. Lerner, E. C., Y. Qian, M. A. Blaskovich, R. D. Fossum, A. Vogt, J. Sun, A. D. Cox, C. J. Der, A. D. Hamilton, and S. M. Sebti. 1995. Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem. 270:26802-26806.
29. Lieber, A., C. Y. He, S. J. Polyak, D. R. Gretch, D. Barr, and M. A. Kay. 1996. Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. J. Virol. 70:8782-8791.
30. Luo, G. X., M. Chao, S. Y. Hsieh, C. Sureau, K. Nishikura, and J. Taylor. 1990. A specific base transition occurs on replicating hepatitis delta virus RNA. J. Virol. 64:1021-1027.
31. Maltese, W. A. 1990. Posttranslational modification of proteins by isoprenoids in mammalian cells. FASEB J. 4:3319-3328.
32. Manock, S. R., P. M. Kelley, K. C. Hyams, R. Douce, R. D. Smalligan, D. M. Watts, T. W. Sharp, J. L. Casey, J. L. Gerin, R. Engle, A. Alava-Alprecht, C. M. Martínez, N. B. Bravo, A. G. Guevara, K. L. Russell, W. Mendoza, and C. Vimos. 2000. An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador. Am. J. Trop. Med. Hyg. 63:209-213.
33. Marsters, J. C., Jr., R. S. McDowell, M. E. Reynolds, D. A. Oare, T. C. Somers, M. S. Stanley, T. E. Rawson, M. E. Struble, D. J. Burdick, K. S. Chan, et al. 1994. Benzodiazepine peptidomimetic inhibitors of farnesyltransferase. Bioorganic Med. Chem. 2:949-957.
34. Nakano, T., C. N. Shapiro, S. C. Hadler, J. L. Casey, M. Mizokami, E. Orito, and B. H. Robertson. 2001. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J. Gen. Virol. 82:2183-2189.
35. Negro, F. 1996. Animal models of hepatitis delta virus infection. Viral Hepatitis Rev. 2:175-185.
36. Ohashi, K., P. L. Marion, H. Nakai, L. Meuse, J. M. Cullen, B. B. Bordier, R. Schwall, H. B. Greenberg, J. S. Glenn, and M. A. Kay. 2000. Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses. Nat. Med. 6:327-331.
37. Otto, J. C., and P. J. Casey. 1996. The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells. J. Biol. Chem. 271:4569-4572.
38. Reiser, J. 2000. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther. 7:910-913.
39. Rizzetto, M. 1983. The delta agent. Hepatology 3:729-737.
40. Rizzetto, M., M. G. Canese, S. Aricò, O. Crivelli, C. Trepo, F. Bonino, and G. Verme. 1977. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 18:997-1003.
41. Rowinsky, E. K., J. J. Windle, and D. D. Von Hoff. 1999. Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development. J. Clin. Oncol. 17:3631-3652.
42. Schafer, W. R., and J. Rine. 1992. Protein prenylation: Genes, enzymes, targets, and functions. Annu. Rev. Genet. 30:209-237.
43. Scudiero, D. A., R. H. Shoemaker, K. D. Paull, A. Monks, S. Tierney, T. H. Nofziger, M. J. Currens, D. Seniff, and M. R. Boyd. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
44. Sureau, C., J. R. Jacob, J. W. Eichberg, and R. E. Lanford. 1991. Tissue culture system for infection with human hepatitis delta virus. J. Virol. 65: 3443-3450.
45. Sureau, C., A. M. Moriarty, G. B. Thornton, and R. E. Lanford. 1992. Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J. Virol. 66: 1241-1245.
46. Taylor, J. M. 1992. The structure and replication of hepatitis delta virus. Annu. Rev. Microbiol. 46:253-276.
47. Wang, K. S., Q. L. Choo, A. J. Weiner, J. H. Ou, R. C. Najarian, R. M. Thayer, G. T. Mullenbach, K. J. Denniston, J. L. Gerin, and M. Houghton. 1986. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature 323:508-514. Erratum: 328:456, 1987.
48. Wu, J. C., P. J. Chen, M. Y. Kuo, S. D. Lee, D. S. Chen, and L. P. Ting. 1991. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J. Virol. 65:1099-1104.
49. Yeh, T. S., and Y. H. Lee. 1998. Assembly of hepatitis delta virus particles: package of multimeric hepatitis delta virus genomic RNA and role of phosphorylation. Virology 249:12-20.
50. Zhang, F. L., and P. J. Casey. 1996. Protein prenylation: molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:241-269.